GlobeNewsWire · CRSP · November 8, 2026

CRISPR Therapeutics Provides Update on Zugocabtagene Geleucel (Zugo-cel) in Refractory Rheumatologic Autoimmune Diseases

Get the app for more

Explore stock news, insights and company research.